LabCompass

Huaxin Zhou

Medicine · Indiana University

Publications

59

Citations

1,141

Est. group size

Recurring co-author estimate

Active years

19

Publishing since 2007

Research summary
AI-generated

Huaxin Zhou studies the molecular biology of liver diseases, particularly how proteins are chemically modified and how cell metabolism is rewired in conditions like fatty liver disease (MASH/NASH), liver fibrosis (scarring), and liver cancers such as hepatocellular carcinoma. A related line of work uses computer simulations to study how drug molecules bind to targets like the EGFR protein, aiding drug discovery. The research combines laboratory experiments, large-scale genetic/molecular ('multi-omics') data analysis, and computational modeling.

Liver disease and liver cancer biologyProtein modification (ubiquitination) and cell signalingCellular metabolism reprogrammingDrug binding simulations and drug discoveryMulti-omics biomarker analysis

Publication activity has grown steadily over the past decade, rising from a couple of papers per year to a peak of eight in 2024, averaging about 4.8 per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.8/year recently
2017: 2 publications172018: 4 publications182019: 3 publications192020: 4 publications202021: 6 publications212022: 5 publications222023: 6 publications232024: 8 publications8242025: 5 publications2526
Recent publications
Publishes in
  • Journal of Separation Science×3
  • Proceedings of IMPRS×3
  • Cell Death and Disease×2
  • Cellular and Molecular Life Sciences×2
  • Biomarker Research×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile